Skip to main content

Embryologie und Teratologie

  • Chapter
  • First Online:
Die Geburtshilfe

Part of the book series: Springer Reference Medizin ((SRM))

  • 13k Accesses

Zusammenfassung

Im Verlauf der intrauterinen Entwicklung durchläuft die Frucht Stadien unterschiedlicher Empfindlichkeit gegenüber äußeren Einflüssen. Während sich die Reaktion auf schädigende Agenzien in den ersten beiden Wochen nach Konzeption weitgehend auf die Alternativen vollständige Heilung des Defekts oder Absterben beschränkt, können Einflüsse von Woche 3–8 nach Konzeption zu Störungen der Organdifferenzierung und damit zu Fehlbildungen führen.

In der Fetalperiode stehen Wachstums- und Funktionsstörungen durch exogene Noxen im Vordergrund.

Seit nach Einnahme von Thalidomid ca. 10.000 Kinder mit schweren Gliedmaßendefekten geboren wurden, herrscht bei pharmazeutischer Industrie, Ärzten und Patientinnen berechtigte Vorsicht gegenüber dem Einsatz von Arzneimitteln in der Schwangerschaft. Ein therapeutischer Nihilismus bei chronisch kranken Schwangeren kann jedoch zu einer dramatischen Verschlechterung der Grunderkrankung und damit zu einer erheblichen Gefährdung der fetalen Entwicklung führen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • ACOG (1994) Substance abuse in pregnancy. ACOG Tech Bull No 195. Int J Gynaecol Obstet 47:73–80

    Article  Google Scholar 

  • ACOG (2003) Immunization during pregnancy. ACOG Committee Opinion No. 282. Obstet Gynecol 101:207–212

    Article  Google Scholar 

  • ACOG Committee on Obstetric Practice (2004) ACOG Committee Opinion Number 299. Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 104:647–651

    Article  Google Scholar 

  • ACOG Committee on Practice Bulletins (2005) Clinical management guidelines for obstetrician-gynecologists. Pregestational diabetes mellitus. Obstet Gynecol 105:675–685

    Article  Google Scholar 

  • Alwan S, Friedman JM (2009) Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 23:493–509

    Article  CAS  PubMed  Google Scholar 

  • Andrade SE et al (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18:246–252

    Article  PubMed  Google Scholar 

  • Antiretrovir Pregnancy Registry Steering Committee (2007) Antiretrovir Pregnancy Registry interim report for 1 January 1989 through 31 Juli 2007, Wilmington

    Google Scholar 

  • Briggs GG, Freeman RK, Yaffe S (2011) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 9. Aufl. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G (1995) Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 172:525–529

    Article  CAS  PubMed  Google Scholar 

  • Campbell E, Kennedy F, Irwin B, Morrison P, Delanty N, Hunt S, Craig J, Morrow J (2013) Malformation risks of antiepileptic drug monotherapies in pregnancy. J Neurol Neurosurg Psychiatry 84:e2

    Article  Google Scholar 

  • Costedoat-Chalumeau N, Amoura Z, Duhaut P, du Huong LT, Sebbough D, Wechsler B, Vauthier D, Denjoy I, Lupoglazoff JM, Piette JC (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48:3207–3211

    Article  CAS  PubMed  Google Scholar 

  • De Santis M, Di Gianantonio E, Cesari E, Ambrosini G, Straface G, Clementi M (2009) First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf 32:239–244

    Article  PubMed  Google Scholar 

  • Degenhardt KH (1971) Pränatale Pathologie: Definition, Häufigkeit, Ätiologie und Pathogenese von Mißbildungen. In: Opitz H (Hrsg) Handbuch der Kinderheilkunde, Bd I/1. Springer, Berlin/Heidelberg/New York, S 602–624

    Google Scholar 

  • DFG – Deutsche Forschungsgemeinschaft (2006) Maximale Arbeitsplatzkonzentrationen und biologische Arbeitsstofftoleranzwerte. VCH, Weinheim

    Google Scholar 

  • Diav-Citrin O, Ornoy A (2002) Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology 65:38

    Article  CAS  PubMed  Google Scholar 

  • Enders G (1991) Infektionen und Impfungen in der Schwangerschaft, 2. Aufl. Urban & Schwarzenberg, München

    Google Scholar 

  • Fried PA, Watkinson B (1990) 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes and alcohol. J Dev Behav Pediatr 11:49–58

    Article  CAS  PubMed  Google Scholar 

  • Fried S, Kozer E, Nulman I, Einarson TR, Koren G (2004) Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf 27:197–202

    Article  PubMed  Google Scholar 

  • Geisler WM (2007) Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 44(Suppl 3):77–83

    Article  Google Scholar 

  • Gisbert JP (2010) Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflamm Bowel Dis 16:881–895

    Article  PubMed  Google Scholar 

  • Gonzalez CH, Marques-Dias MJ, Kim CA (1998) Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351:1624–1627

    Article  CAS  PubMed  Google Scholar 

  • Harden CL et al (2009a) Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73:133–141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harden CL et al (2009b) Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73:142–149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, Allignol A, Weber-Schoendorfer C, Schaefer C (2013) Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 158:588–596

    Google Scholar 

  • Hyoun SC, Obican SG, Scialli AR (2012) Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol 94:187–207

    Article  CAS  PubMed  Google Scholar 

  • Jamieson DJ, Novel Influenza A (H1N1) Pregnancy Working Group et al (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374:451–458

    Article  PubMed  Google Scholar 

  • Kallen BA, Otterblad Olausson P (2007) Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79:301–308

    Article  PubMed  Google Scholar 

  • Kalter H, Warkany J (1983) Congenital malformations. N Engl J Med 308:491–497

    Article  CAS  PubMed  Google Scholar 

  • Keller F, Griesshammer M, Haussler U, Paulus W, Schwarz A (2001) Pregnancy and renal failure: the case for application of dosage guidelines. Drugs 61:1901–1920

    Article  CAS  PubMed  Google Scholar 

  • Knörr K, Knörr-Gärtner H, Beller FK, Lauritzen C (1989) Geburtshilfe und Gynäkologie. Physiologie und Pathologie der Reproduktion, 3. Aufl. Springer, Berlin/Heidelberg/New York

    Book  Google Scholar 

  • Lamotrigine Pregnancy Registry (2008) Interim report. September 1992 through 30 September 2007, Wilmington, Jan 2008

    Google Scholar 

  • Lennestål R, Källén B (2007) Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 27:607–613

    Article  PubMed  Google Scholar 

  • Mahadevan U, Cucchiara S, Hyams JS, Steinwurz F, Nuti F, Travis SP, Sandborn WJ, Colombel JF (2011) The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European Crohn’s and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol 106:214–223

    Article  CAS  PubMed  Google Scholar 

  • McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Serafini MA, Arnon J, Rodriguez-Pinilla E, Schaefer C, Pexieder T, Merlob P, dal Verme S (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. Reprod Toxicol 10:285–294

    Article  CAS  PubMed  Google Scholar 

  • McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SHL (1999) Congenital anomalies after prenatal ecstasy exposure. Lancet 154:1441–1442

    Article  Google Scholar 

  • Merlob P, Stahl B, Klinger G (2009) Tetrada of the possible mycophenolate mofetil embryopathy: a review. Reprod Toxicol 28:105–158

    Article  CAS  PubMed  Google Scholar 

  • Mølgaard-Nielsen D, Pasternak B, Hviid A (2013) Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med 369:830–839

    Article  PubMed  Google Scholar 

  • Moretti ME, Bar-Oz B, Fried S, Koren G (2005) Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 16:216–219

    Article  PubMed  Google Scholar 

  • Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry 77:193–198

    Article  CAS  PubMed  Google Scholar 

  • Mulligan ML, Felton SK, Riek AE, Bernal-Mizrachi C (2010) Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 202:429.e1–429.e9

    Article  Google Scholar 

  • Nahum GG, Uhl K, Kennedy DL (2006) Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 107:1120–1138

    Article  CAS  PubMed  Google Scholar 

  • Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JGW, Kulin N, Koren G (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336:258–262

    Article  CAS  PubMed  Google Scholar 

  • Oren D, Nulman I, Makhija M, Ito S, Koren G (2004) Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Physician 50:1083–1085

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28:1–10

    Article  CAS  PubMed  Google Scholar 

  • Pasternak B, Svanström H, Hviid A (2013) Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med 368:814–823

    Article  CAS  PubMed  Google Scholar 

  • Paulus WE, Lauritzen C (2014) Medikamente und Schadstoffe in Schwangerschaft und Stillzeit. 23. Aktualisierung. Spitta, Balingen

    Google Scholar 

  • Polifka JE, Friedman JM (2002) Teratogen update: azathiprine and 6-mercaptopurine. Teratology 65:240–261

    Article  CAS  PubMed  Google Scholar 

  • Rösch C, Steinbicker V (2003) Aetiology of congenital malformations – analysis of malformation registry data compared with the Kalter & Warkany study. Reprod Toxicol 17:503–504

    Google Scholar 

  • Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P (2006) Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 95:949–957

    CAS  PubMed  Google Scholar 

  • Scialli AR, Ang R, Breitmeyer J, Royal MA (2010) A review of the literature on the effects of acetaminophen on pregnancy outcome. Reprod Toxicol 30:495–507

    Article  CAS  PubMed  Google Scholar 

  • Sellinger CP, Leong RW, Lal S (2012) Pregnancy related issues in inflammatory bowel disease: evidence base and patients’ perspective. World J Gastroenterol 18:2600–2608

    Article  Google Scholar 

  • Shepard TH, Brent RL, Friedman JM, Jones KL, Miller RK, Moore CA, Polifka JE (2002) Update on new developments in the study of human teratogens. Teratology 65:153–161

    Article  CAS  PubMed  Google Scholar 

  • Snijder CA, Kortenkamp A, Steegers EA, Jaddoe VW, Hofman A, Hass U, Burdorf A (2012) Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod 27:1191–1201

    Article  PubMed  Google Scholar 

  • Ständige Impfkommission am Robert Koch-Institut – STIKO (2010) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epid Bull 31/2010

    Google Scholar 

  • Steinhausen HC, Willms J, Spohr HL (1995) Die Berliner Verlaufsstudie von Kindern mit einem Fetalen Alkoholsyndrom (FAS). 2. Psychiatrische und psychologische Befunde. Monatsschr Kinderheilkd 143:157–164

    Google Scholar 

  • Streissguth AP, Barr HM, Sampson PD (1990) Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res 14:662–669

    Article  CAS  PubMed  Google Scholar 

  • Streissguth AP, Aase JM, Clarren SK, Randels SP, La Due RA, Smith DF (1991) Fetal alcohol syndrome in adolescents and adults. JAMA 265:1961–1967

    Article  CAS  PubMed  Google Scholar 

  • Tunks RD, Clowse ME, Miller SG, Brancazio LR, Barker PC (2013) Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am J Obstet Gynecol 208:64.e1–64.e7

    Article  CAS  Google Scholar 

  • van Driel D, Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Heymans HS (2002) Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 66:127–140

    Article  PubMed  Google Scholar 

  • Vauzelle C, Beghin D, Cournot MP, Elefant E (2013) Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study. Reprod Toxicol 36:98–103

    Article  CAS  PubMed  Google Scholar 

  • Wilson JD (1977) Embryotoxicity of drugs to man. In: Wilson JD, Frazer FC (Hrsg) Handbook of teratology. Plenum, New York, S 309–355

    Chapter  Google Scholar 

  • Yacobi S, Ornoy A (2008) Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci 45:95–106

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang E. Paulus .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Paulus, W.E. (2016). Embryologie und Teratologie. In: Schneider, H., Husslein, P., Schneider, KT. (eds) Die Geburtshilfe. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45064-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45064-2_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45063-5

  • Online ISBN: 978-3-662-45064-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics